FDA approves safety-label revisions for several products

05/14/2009 | Medscape (free registration)

The FDA approved revisions to the safety labels on several drug products, including regadenoson injection, which is used as a pharmacologic stress agent for radionucleotide myocardial perfusion imaging. The revised label for regadenoson will include information about the drug's potential to cause heart block and hypotension in some patients.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA